Genmab A (GMAB) Shares Outstanding (Diluted) (2023 - 2026)
Genmab A (GMAB) recorded Shares Outstanding (Diluted) of 62.69 million in the quarter ended Jun 30, 2026, unchanged from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
Starting with the quarter ended Jun 30, 2018, Genmab A's Shares Outstanding (Diluted) history includes 28 quarters.
- Annual Shares Outstanding (Diluted) has a five-year compound annual growth rate of -0.3% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Shares Outstanding (Diluted) came in at 64.66 million in the year ended Dec 31, 2024 (-1.9%), 65.9 million in the year ended Dec 31, 2023 (+3.6%), 63.64 million in the year ended Dec 31, 2022 (unchanged) and 63.64 million in the year ended Dec 31, 2021 (unchanged).
- Quarterly Shares Outstanding (Diluted) has ranged from 62.69 million in the quarter ended Dec 31, 2025 to 65.9 million in the quarter ended Sep 30, 2024 over the past five years.
- Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 3.6% in the quarter ended Dec 31, 2023, against a decline of 3.0% in the quarter ended Dec 31, 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Genmab A | 2.87 Bn | -2.51 Bn | 1.07 Bn | 62.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.69 Mn |
| Mar 31, 2026 | 62.69 Mn |
| Dec 31, 2025 | 62.69 Mn |
| Sep 30, 2025 | 64.66 Mn |
| Jun 30, 2025 | 64.66 Mn |
| Mar 31, 2025 | 64.66 Mn |
| Dec 31, 2024 | 64.66 Mn |
| Sep 30, 2024 | 65.90 Mn |
| Jun 30, 2024 | 65.90 Mn |
| Mar 31, 2024 | 65.90 Mn |
| Dec 31, 2023 | 65.90 Mn |
| Sep 30, 2023 | 63.64 Mn |
| Mar 31, 2023 | 63.64 Mn |
| Jan 1, 2023 | 63.64 Mn |
API Access
Genmab A Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();